KDIGO Conversations in Nephrology
Episode 34: The Rationale for Complement Inhibition in the Management of IgA Nephropathy
· 15 min
Show notes
In Episode 34, the first in a three-part Conversations in Nephrology series on IgA nephropathy (IgAN), host Brad Rovin, MD (The Ohio State University), KDIGO IgAN/IgAV Guideline Co-Chair, is joined by Dana Rizk, MD (University of Alabama at Birmingham), to explore the rationale for complement inhibition in the management of IgAN.
Dr. Rovin and Dr. Rizk examine the evidence linking the complement system to IgAN, drawing on experimental research and genome-wide association studies. They discuss the roles of the lectin, alternative, and terminal complement pathways and the rationale for…
Website: podcasters.spotify.com
